Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/2013 - 12/2015

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS, Health care costs, Health care economics, Health care expenditures

Citation

Authors

Peng S, Tafazzoli A, Dorman E, Rosenblatt L, Villasis-Keever A, Sorensen S

Journal

J Med Econ

Volume

Issue

Pages

763-76

Publication year

2015

Suggested citation

Peng S, Tafazzoli A, Dorman E, Rosenblatt L, Villasis-Keever A, Sorensen S. Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States. J Med Econ. 2015; 18(10): 763-76.

DOI

10.3111/13696998.2015.1046878

PMID

25934146

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States

Nav